There is no federal jurisdiction over a consumer-protection lawsuit involving claims of allegedly defective dialysis products because there is not complete diversity of citizenship between the parties, Mississippi’s attorney general argues in a recent court filing.
Mississippi is prosecuting the lawsuit against Fresenius Medical Care Holdings Inc. over the allegations that its dialysis products, GranuFlo or NaturaLyte, cause unsafe changes in patients’ blood pH.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
